EQL Pharma AB (EQL)

Currency in SEK
83.6000
0.0000(0.00%)
Delayed Data·

EQL Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
0.44 / 0.45
Revenue / Forecast
113.26M / 102.75M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/----/114.2M----Free Sign Up
03/20250.44/0.45113.26M/102.75M-2.22%+10.23%Free Sign Up
12/20240.35/0.4692M/94.75M-23.91%-2.9%Free Sign Up
09/20240.33/0.2285.1M/85M+50%+0.12%Free Sign Up
06/20240.36/0.2882.9M/82.9M+28.57%0%Free Sign Up
03/20240.16/0.1678.1M/78.1M0%0%Free Sign Up
12/20230.22/0.2270.1M/70M0%+0.14%Free Sign Up
09/20230.16/0.1660M/59.87M0%+0.22%Free Sign Up
06/20230.23/--56M/56M--0%Free Sign Up
03/20230.14/--60.33M/------Free Sign Up

All numbers in SEK

EQL Pharma AB Earnings Call Summary for Q1/2026

  • Revenue surged 30% YoY to SEK 107M, beating forecasts; EPS slightly missed at 0.44 vs 0.45 expected
  • Stock rose 2.22% post-earnings; company maintains 30% full-year growth target and aims for 25% EBITDA margin
  • Expansion into Germany and Netherlands underway; Special Generics unit launched with products expected by 2026
  • CEO emphasized European rollout and business investment; company aims to reduce leverage from 3.7x to 2.5x EBITDA
  • Medilink acquisition integration on track; cautious optimism expressed regarding future M&A opportunities
Last Updated: 08/08/2025, 13:22
Read Full Transcript

FAQ

What Is EQL Pharma's Earnings Per Share (TTM)?

The EQL Pharma EPS (TTM) is 1.46.

When Is The Next EQL Pharma Earnings Date?

EQL Pharma will release its next earnings report on 06 Nov 2025.

What Is EQL Pharma’s Revenue Forecasts For Upcoming Quarters?

EQL Pharma’s revenue forecast is 117.85M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.